2014 IPOs - The Wall Street Transcript

The Wall Street Transcript - In-Depth Interviews for Investors

April 23, 2015

Topics covered: Technology in the Retail Sector, Reducing Drug Development Risk, Pharmaceutical Market Opportunities, New-Build Construction, Diabetic Pharmaceuticals, Clinical Trials, Asset-Light Businesses, Acquisitions for Growth

Companies covered: Biocept, Inc. (NASDAQ:BIOC), Borderfree, Inc. (NASDAQ:BRDR)

Interview with the President & CEO and Senior Vice President & CFO: Biocept, Inc. (BIOC)
Michael W. Nall; Bill Kachioff

Interview with the CEO: Sysorex Global Holdings Corp. (SYRX)
Nadir Ali

Interview with the President and CEO: Signal Genetics, Inc. (SGNL)
Samuel D. Riccitelli

Interview with the VP, Finance and Corporate Development: Dipexium Pharmaceuticals, Inc. (DPRX)
David Garrett

Interview with the CEO and President: Borderfree, Inc. (BRDR)
Michael DeSimone

Interview with the SVP, Finance and Investor Relations: Installed Building Products, Inc. (IBP)
Jason R. Niswonger

Interview with the Scientific Founder, President and CEO: Concert Pharmaceuticals, Inc. (CNCE)
Roger D. Tung

Interview with the CFO: Galmed Pharmaceuticals Ltd. (GLMD)
Josh Blacher